Homburger advised allosteric modulation company Addex Therapeutics in Plan-les-Ouates, Geneva (SIX: ADXN) in the completion of an equity financing transaction with a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 7,999,998 shares
Seamless Therapeutics, a German biotechnology firm, has successfully concluded a USD12.5 million Seed Financing, a university carve-out including equity financing, in-licensing of an innovative patent portfolio from Technische Universität Dresden and hiring of key
Swiss-based travel-tech start-up, Boddy, has entered into a binding merger agreement with TrainAway, a Danish company, to form the largest wellbeing network for travelers worldwide. By affiliating with TrainAway, Boddy will leverage the Danish
Lonza Swiss Finance, a wholly owned subsidiary of the Lonza Group, has successfully placed CHF 300 million 2.1% guaranteed senior bonds due 2029. Credit Suisse, UBS
Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases, is to be sold to Genfit. With this acquisition, Genfit intends to expand its product portfolio
Advestra has advised Gnothis on all legal aspects related the two financing rounds of nearly CHF 10 million. Gnothis Holding is a company active in the health sector and has closed this fin
Mosanna Therapeutics, a Basel-based biotechnology company, has closed a Seed Financing Round led by Forty51 Ventures. The proceeds will be used for formulation and manufacturing optimization of the molecule MOS118 and for regulatory activities in
As we announced on February, Promedical, which was acquired earlier this year by a group of investors led by SME Equity Partners and Co-Investor Partners and acting through its parent company, has acquired Lauerz-based Nizell
Swiss biotech company, Engimmune Therapeutics completes its seed financing round raising CHF 15.5 million, co-led by Pureos Bioventures and Novo Holdings with incubation from BaseLaunch. Engimmune Therapeutics is a platform company using cutting-edge technologies
Sonova Holding, providers of hearing aid solutions, has completed the placement of CHF 450 million Bonds governed by Swiss law. Application will be made for the Bonds to be listed on the SIX Swiss Exchange. The
